A practical and evidence-based approach to cardiovascular disease risk reduction

被引：46

作者：

Gluckman, TJ ^{[1
]}

Baranowski, B ^{[1
]}

Ashen, D ^{[1
]}

Henrikson, CA ^{[1
]}

McAllister, M ^{[1
]}

Braunstein, JB ^{[1
]}

Blumenthal, RS ^{[1
]}

机构：

[1] Johns Hopkins Univ, Sch Med, Dept Med, Cardiol Div,Ciccarone Prevent Cardiol Ctr, Baltimore, MD 21205 USA

来源：

ARCHIVES OF INTERNAL MEDICINE | 2004年 / 164卷 / 14期

关键词：

D O I：

10.1001/archinte.164.14.1490

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Implementation of the numerous lifestyle and medical management options for secondary prevention of cardiovascular disease remains a daunting goal for primary care physicians and cardiologists alike. Despite the existence of expert consensus guidelines on cardiovascular prevention by the American College of Cardiology and the American Heart Association, therapies known to improve patient care and decrease morbidity and mortality remain underutilized. This, review attempts to simplify cardiovascular risk reduction by summarizing key clinical trials in an "ABC" format. We believe that if health care providers and patients use such a format, important lifestyle and pharmacologic options will more likely be addressed.

引用

页码：1490 / 1500

页数：11

共 141 条

[71] SUDDEN CORONARY DEATH - THE FRAMINGHAM-STUDY [J].

KANNEL, WB ;

THOMAS, HE .

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1982, 382 (MAR) :3-21

[72] Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy -: A Losartan Intervention For Endpoint Reduction (LIFE) substudy [J].

Kjeldsen, SE ;

Dahlöf, B ;

Devereux, RB ;

Julius, S ;

Aurup, P ;

Edelman, J ;

Beevers, G ;

de Faire, U ;

Fyhrquist, F ;

Ibsen, H ;

Kristianson, K ;

Lederballe-Pedersen, O ;

Lindholm, LH ;

Nieminen, MS ;

Omvik, P ;

Oparil, S ;

Snapinn, S ;

Wedel, H .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (12) :1491-1498

[73]

Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512

[74] β-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction [J].

Ko, DT ;

Hebert, PR ;

Coffey, CS ;

Sedrakyan, A ;

Curtis, JP ;

Krumholz, HM .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (03) :351-357

[75] A CLINICAL-TRIAL OF THE ANGIOTENSIN-CONVERTING-ENZYME INHIBITOR TRANDOLAPRIL IN PATIENTS WITH LEFT-VENTRICULAR DYSFUNCTION AFTER MYOCARDIAL-INFARCTION [J].

KOBER, L ;

TORPPEDERSEN, C ;

CARLSEN, JE ;

BAGGER, H ;

ELIASEN, P ;

LYNGBORG, K ;

VIDEBEK, J ;

COLE, DS ;

AUCLERT, L ;

PAULY, NC ;

ALIOT, E ;

PERSSON, S ;

CAMM, AJ .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (25) :1670-1676

[76]

LANCASTER T, 2002, COCHRANE DATABASE SY

[77] The underlying risk of death after myocardial infarction in the absence of treatment [J].

Law, MR ;

Watt, HC ;

Wald, NJ .

ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (21) :2405-2410

[78]

Lechat P, 1999, LANCET, V353, P9

[79] Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes [J].

Lewis, EJ ;

Hunsicker, LG ;

Clarke, WR ;

Berl, T ;

Pohl, MA ;

Lewis, JB ;

Ritz, E ;

Atkins, RC ;

Rohde, R ;

Raz, I .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) :851-860

[80] Walking compared with vigorous exercise for the prevention of cardiovascular events in women [J].

Manson, JE ;

Greenland, P ;

LaCroix, AZ ;

Stefanick, ML ;

Mouton, CP ;

Oberman, A ;

Perri, MG ;

Sheps, DS ;

Pettinger, MB ;

Siscovick, DS .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (10) :716-725

← 3 4 5 6 7 8 9 10 11 12 →